https://sputnikglobe.com/20211109/russias-gamaleya-center-developing-medicine-containing-antibodies-to-treat-covid-1090606634.html
Russia's Gamaleya Centre Developing Medicine Containing Antibodies to Treat COVID
Russia's Gamaleya Centre Developing Medicine Containing Antibodies to Treat COVID
Sputnik International
MOSCOW (Sputnik) - Russia's Gamaleya National Research Centre of Epidemiology and Microbiology is developing a medicine containing antibodies to treat... 09.11.2021, Sputnik International
2021-11-09T22:52+0000
2021-11-09T22:52+0000
2021-11-10T04:33+0000
russia
medicine
gamaleya research institute of epidemiology and microbiology
pandemic
covid-19
https://cdn1.img.sputnikglobe.com/img/07e4/0c/02/1081331417_0:177:3073:1905_1920x0_80_0_0_0b2574fc636b04f887170a0d2463ee8d.jpg
"We are currently developing antibodies that can be given to patients with coronavirus in the form of a medicine", Gintsburg said."We will start clinical trials in January next year, and I hope that we will complete these clinical trials within three to four months", Gintsburg added.Concerning the issue of using a nasal vaccine against the new coronavirus infection instead of ordinary vaccination, he said that it will be decided during clinical trials, and there is no definite answer yet.The Gamaleya Research Centre developed the world's first vaccine for the prevention of COVID-19, Sputnik V.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
medicine, gamaleya research institute of epidemiology and microbiology, pandemic, covid-19
medicine, gamaleya research institute of epidemiology and microbiology, pandemic, covid-19
Russia's Gamaleya Centre Developing Medicine Containing Antibodies to Treat COVID
22:52 GMT 09.11.2021 (Updated: 04:33 GMT 10.11.2021) MOSCOW (Sputnik) - Russia's Gamaleya National Research Centre of Epidemiology and Microbiology is developing a medicine containing antibodies to treat coronavirus patients, the centre's director, Alexander Gintsburg, told Sputnik.
"We are currently developing antibodies that can be given to patients with coronavirus in the form of a medicine", Gintsburg said.
"We will start clinical trials in January next year, and I hope that we will complete these clinical trials within three to four months", Gintsburg added.
Concerning the issue of using a nasal vaccine against the new coronavirus infection instead of ordinary vaccination, he said that it will be decided during clinical trials, and there is no definite answer yet.
"The question is good, correct, there is no unequivocal answer to this. During the clinical trials for which we have received permission, one of the questions that will be resolved... will be the one that you have now asked me", Gintsburg said when asked whether the nasal vaccine against COVID-19 could replace an injection or will be used as a supplement to it, for example, during revaccination.
The Gamaleya Research Centre developed the
world's first vaccine for the prevention of COVID-19, Sputnik V.
